Single-use

Spanish Company Revolutionizes Personalized Medicine

📢 A Spanish company, TECNIC Bioprocess Solutions, has been selected for phase 1 of a pre-commercial public procurement for the development of an intelligent platform for single-use bioreactors. 👨‍⚕️ The collaboration between TECNIC Bioprocess Solutions and BYOTIC aims to advance personalized medicine and innovative therapies. 🔬 The project focuses on the development of single-use bioreactors for autologous cell therapy, reducing the need for repeated sterilization and contamination risks. 💡 TECNIC's innovative design incorporates advanced perfusion technology and control software for optimal production of cell-based biopharmaceuticals. ♻️ The modular and flexible design of the bioreactors enhances sustainability and adaptability, reducing costs and improving production efficiency. 🤝 Strategic collaborations with leading institutions such as Universitat Autònoma de Barcelona and Banc de Sang i Teixits de Catalunya strengthen research and development capabilities. 💪 This project not only improves personalized treatments but also sets new standards for efficient and safe production of biopharmaceuticals. 🌍 TECNIC's advancements in bioprocessing technology contribute to a future where personalized medicine is accessible to all, transforming healthcare. 💼 TECNIC Bioprocess Solutions' contribution to knowledge creation and technology transfer fosters economic and technological development.